Table 2.

Proportion of patients with electronic health records of medication prescription and/or lifestyle support in a period of 12 months before to 12 months after initial diagnosis for each condition.

	Hypertension		Hyperlipidaemia		Obesity
Treatment	(N = 403,129)		(N = 105,900)		(N = 261,682)
	Per cent (95% CI)	n	Per cent (95% CI)	n	Per cent (95% CI)	n
None	12.2 (11.9–12.5)	49,039	32.2 (31.2–33.3)	34,144	43.9 (42.3–45.4)	114,789
Medication
Medication only	32.2 (31.5–32.9)	129,821	22.5 (21.6–23.5)	23,858	3.5 (3.3–3.7)	9231
Medication w/signposting	8.7 (8.4–9.1)	35,210	4.1 (3.8–4.4)	4,355	0.9 (0.8–1.0)	2364
Medication w/ lifestyle   intervention	41.1 (40.3–41.8)	165,575	17.6 (16.9–18.3)	18,623	3.7 (3.5–3.9)	9769
Lifestyle support
Lifestyle Intervention only	4.7 (4.4–5.0)	18,917	17.8 (16.6–19.0)	18,834	38.4 (37.0–39.7)	100,441
Signposting only	1.1 (1.0–1.2)	4,567	5.7 (5.3–6.2)	6,086	9.6 (9.0–10.3)	25,088
Total	100	403,129	100	105,900	100	261,682
	Prop. (95% CI)	n	Prop. (95% CI)	n	Prop. (95% CI)	n
All patients with medication  record	82.0 (81.6–82.4)	330,606	44.2 (42.8–45.6)	46,836	8.2 (7.7–8.6)	21,364
All patients with lifestyle  support record	55.6 (54.9–56.4)	224,269	45.2 (43.8–46.6)	47,898	52.6 (51.1–54.1)	137,662
All patients with medication  and/or lifestyle support  record	87.8 (87.5–88.1)	354,090	67.8 (66.7–68.8)	71,756	56.1 (54.6–57.7)	146,893

CI: confidence interval. Table shows the proportions of patients by treatment group and condition. The patient must have a record of a given treatment at any point between 12 months prior to and/or 12 months after their initial diagnosis. Confidence intervals were computed with standard errors using a variance-stabilising transformation for the binomial distribution and are clustered at the practice level. Patients that have received a lifestyle intervention may have also concurrently received signposting.